Sirtris Pharmaceuticals

Sirtris Pharmaceuticals was a biopharmaceutical company that developed therapies for type 2 diabetes, cancer, and other diseases. Sirtris went public in 2007 and was then acquired by GlaxoSmithKline in 2008.